Brand page
Continuous investment in R&D for global leadership in biotech industry
Lab Introduction
Lab Introduction
The RFBIO Toxin Research Center is committed to leading innovation in the field through groundbreaking research and development of toxin products.
Leveraging the world's first and only strain of Clostridium botulinum derived from wild honey, our center endeavors to revolutionize the industry.
RFBIO Botulinum Toxin
Our proprietary lyophilized injectable botulinum
neurotoxin, extracted from this unique strain,
specifically focuses on the purification of type A neurotoxin for enhanced efficacy and safety.
Development Progress
  • 2023
    Commencement of toxicity testing conducted by a GLP certified agency regulated by the Republic of Korea's Ministry of Food and Drug Safety
    Submission of two patent applications for the development of a proprietary strain and manufacturing process
  • 2022
    Implementation of pilot-scale process development to prepare for non-clinical trials
    Initiation of construction for a manufacturing facility dedicated to production of botulinum toxin in Wonju-si, Gangwon-do, Republic of Korea
  • 2021
    Recognition as a government project by the Ministry of Trade, Industry, and Energy (2021~2023)
    Commencement of manufacturing process development utilizing LMO botulinum strain
  • 2020
    Commencement of research and development focusing on Clostridium botulinum strain sourced from natural material, particularly honey
    Successful isolation and identification of proprietary wild honey-derived strain (Registered with the Korea Disease Control and Prevention Agency)
  • 2019
    Completion of declaration for handling High-risk pathogens in research facilities (Korea Disease Control and Prevention Agency)
    Fulfillment of notification requirements for the production of biological agents (Ministry of Trade, Industry, and Energy)
1. Personal Data Collection:

RF Bio Co., Ltd. (hereinafter referred to as the "Company") processes the following personal data:

1) Customer Consultation Service Operation: Company name, personal name, contact information, email address, complaint details.
2) The following personal data may be automatically generated and collected during the use of internet services
: IP address, cookie, access log, MAC address, service usage record, visit record, misuse record, etc.

2. Purpose of Personal Data Processing:
The Company processes personal data for the following purposes. Personal data being processed will not be used for purposes other than the following. If the purpose of use changes, necessary measures such as obtaining separate consent will be taken in accordance with Article 18 of the Personal Information Protection Act:

To operate customer consultation services, personal data is processed for verifying the identity of the complainant, confirming the complaint, contacting and notifying for factual investigation, and notifying the result of processing.

3. Processing and Retention Period of Personal Data:
The Company processes and retains personal data within the personal data retention and use period as stipulated by law or within the agreed-upon personal data retention and use period when collecting personal data from the data subject. It is retained during the period of customer service operation and is not used for any other purpose.

4. Right to Refuse Consent to Collection and Use of Personal Data:
Users have the right to disagree with the above collection and use of personal data. However,
the collection and use of personal data are essential for the Company to operate the site, and users who do not agree to the collection and use of personal data are restricted from using customer consultation services.